Growing community of inventors

Mumbai, India

Nabajyoti Deka

Average Co-Inventor Count = 4.67

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Nabajyoti DekaSomesh Sharma (11 patents)Nabajyoti DekaAshok Kumar Gangopadhyay (7 patents)Nabajyoti DekaSivaramakrishnan Hariharan (3 patents)Nabajyoti DekaSwapnil Ramesh Bajare (3 patents)Nabajyoti DekaRosalind Adaikalasamy Marita (3 patents)Nabajyoti DekaTaj Usman Khan (1 patent)Nabajyoti DekaKamlesh Jyotindra Padiya (1 patent)Nabajyoti DekaRhushikesh Arun Kulkarni (1 patent)Nabajyoti DekaJessy Anthony (0 patent)Nabajyoti DekaAditee Ghate (0 patent)Nabajyoti DekaKumar Venkata Subrahmanya Nemmani (0 patent)Nabajyoti DekaAditya Kelkar (0 patent)Nabajyoti DekaSujit Kaur Bhumra (0 patent)Nabajyoti DekaNabajyoti Deka (3 patents)Somesh SharmaSomesh Sharma (11 patents)Ashok Kumar GangopadhyayAshok Kumar Gangopadhyay (7 patents)Sivaramakrishnan HariharanSivaramakrishnan Hariharan (6 patents)Swapnil Ramesh BajareSwapnil Ramesh Bajare (3 patents)Rosalind Adaikalasamy MaritaRosalind Adaikalasamy Marita (3 patents)Taj Usman KhanTaj Usman Khan (1 patent)Kamlesh Jyotindra PadiyaKamlesh Jyotindra Padiya (1 patent)Rhushikesh Arun KulkarniRhushikesh Arun Kulkarni (1 patent)Jessy AnthonyJessy Anthony (0 patent)Aditee GhateAditee Ghate (0 patent)Kumar Venkata Subrahmanya NemmaniKumar Venkata Subrahmanya Nemmani (0 patent)Aditya KelkarAditya Kelkar (0 patent)Sujit Kaur BhumraSujit Kaur Bhumra (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Piramal Healthcare Limited (2 from 5 patents)

2. Piramal Life Sciences Limited (1 from 21 patents)


3 patents:

1. 8349862 - Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia

2. 8269010 - 3-amino-pyridine derivatives for the treatment of metabolic disorders

3. 8030324 - Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…